Several area organizations are using quilts to raise public awareness of the importance of early screening for cervical ...

Researchers have turned artificial intelligence into a powerful new lens for understanding why cancer survival rates differ ...

Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of ...

Providing patient-centered education and navigation support significantly increases consent rates for genomic testing, making ...

The early-stage clinical trial marks the first U.S. testing of Alveltamig, an immunotherapy designed to help the immune ...

Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point ...

To opt-out click on “Do Not Sell or Share My Personal Information” in the website footer, or to learn more, please visit our ...

Gene that drops early in pancreatic tumors linked to shorter survival at stage II. Findings could guide future treatment ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

A newly developed radiopharmaceutical pair can precisely detect and effectively treat--completely eradicating tumors in ...

Oncolytics also recently expanded its Scientific Advisory Board with globally recognized experts from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center, positioning the company for ...

The Immune Atlas identifies immune signatures in MM, enhancing outcome prediction and guiding personalized therapies by ...